Much research has been done exploring the role of SRC-3 in carcinogenesis through the regulation of oncoproteins and transcription factors in solid tumors, but the role of SRC-3 in blood cancers is less clear. Here, NCOA3 is linked to hematopoietic and lymphoid system neoplasm.